APA

Gotti E., Suter F., Baruzzo S., Perani V., Moioli F. & Remuzzi G. (19970403). Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia. : Clinical transplantation.

Chicago

Gotti E, Suter F, Baruzzo S, Perani V, Moioli F and Remuzzi G. 19970403. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia. : Clinical transplantation.

Harvard

Gotti E., Suter F., Baruzzo S., Perani V., Moioli F. and Remuzzi G. (19970403). Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia. : Clinical transplantation.

MLA

Gotti E, Suter F, Baruzzo S, Perani V, Moioli F and Remuzzi G. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia. : Clinical transplantation. 19970403.